Oral and Maxillofacial Medicine : the basis of diagnosis and treatment /

I have also added new material and clinical pictures, tables, boxes and algorithms. Advisers have requested more information on drug interactions and contraindications, but dissuaded me from adding too many additional clinical pictures, suggesting that Atlases were most suitable for these. I have a...

Full description

Bibliographic Details
Main Author: Scully, Crispian
Format: Electronic
Language:English
Published: [China] : Churchill Livignston, 2013.
Edition:3a.ed.
Subjects:
Online Access:Descarga texto completo en campus U.N.C.

MARC

LEADER 00000nmm a22000007a 4500
008 170726p2013 xxu||||| |||| 00| 0 eng d
952 |0 0  |1 0  |2 black  |4 0  |6 RE_D6_S437  |7 0  |8 BM  |9 17192  |a ODO  |b ODO  |c RE  |d 2017-07-26  |l 0  |o RE D6 S437  |p 011744  |r 2017-07-26  |w 2017-07-26  |y URL 
999 |c 4369  |d 4368 
020 |a 9780702049484 
040 |a AR-CdUFO 
100 |9 5363  |a Scully, Crispian 
245 1 0 |a Oral and Maxillofacial Medicine :  |b the basis of diagnosis and treatment /  |c Crispian Scully 
250 |a 3a.ed. 
260 |a [China] :  |b Churchill Livignston,  |c 2013. 
300 |a 435 p. ;  |g 15 archivos pdf. :  
500 |a  Recurso electrónico disponible desde la Biblioteca Electrónica de Mincyt. 
505 4 |a Front Matter, Copyright, Preface to third edition, Preface to second edition, Preface to first edition, Learning aims and objectives, Intended learning outcomes. Section 1: Fundamental Principles of Patient Management. Section 2: Common Complaints. Section 3: Cancer and Potentially Malignant Disorders. Section 4: Common and Important Orofacial Conditions. Section 5: Relevant Systemic Disorders. Section 6: Eponymous and Other Conditions. Glossary. Index. 
520 4 |a I have also added new material and clinical pictures, tables, boxes and algorithms. Advisers have requested more information on drug interactions and contraindications, but dissuaded me from adding too many additional clinical pictures, suggesting that Atlases were most suitable for these. I have also increased the content in terms of expansion and rearrangement of the section dealing with potentially malignant disorders and cancer; added new material on the genetic influences in many conditions; and added some fairly recently recognised relevant conditions including various adverse drug reactions, autonomic neuropathies, drug-induced hypersensitivity syndrome, hypereosinophilic syndrome, immune reconstitution inflammatory syndrome (IRIS), IgG4 syndrome, lichenoid and granulomatous stomatitis, trigeminal autonomic cephalgias (TACs), TUGSE (traumatic ulcerative granuloma with stromal eosinophilia), and a new oral mucosal condition similar to orofacial granulomatosis described in solid organ-transplanted children. Finally, I have also expanded therapeutics – including emergent therapies. Few of the agents used in oral medicine have been produced specifically for orofacial diseases, many also being employed in other fields such as dermatology, rheumatology and gastroenterology and their use in orofacial disease is often ‘off label’. Some complementary medicine products are also increasingly in use, with an even weaker evidence base. Few agents have thus been tested in randomized controlled double blind clinical trials but, nevertheless, I have endeavoured to highlight the level of evidence for the various therapies most commonly used and introduced a ‘likely benefit’ scheme similar to that used in Clinical Evidence – the British Medical Journal publication. There will always be some controversy between the categories ‘likely to be beneficial’ and ‘unproven effectiveness’. The evidence base is often sparse and changing but patients must be offered some help and hope. 
650 4 |9 114  |a Medicina oral 
650 4 |9 8750  |a Procedimientos quirúrgicos orales 
650 4 |9 8328  |a Neoplasias de la boca 
856 |u http://www.sciencedirect.com/science/book/9780702049484  |z Descarga texto completo en campus U.N.C. 
942 |2 black  |c URL